Chairman of the Board, CEO and President
Kevin Sharer has been Amgen's chief executive officer and president since May 2000, and he has also been chairman of the company's Board of Directors since January 2001. From October 1992 to May 2000, Sharer was Amgen's president and chief operating officer. He has been a director of Amgen since November 1992.
Before joining Amgen, Sharer was president of the Business Markets Division of MCI Communications. Prior to MCI, Sharer served in a variety of executive capacities at General Electric and was a consultant for McKinsey & Company. Sharer serves on the Board of Directors of Northrop Grumman Corporation and Chevron. He is a trustee of the California Institute of Technology (Caltech).
Amgen is a leading human therapeutics company in the biotechnology industry. For nearly 30 years, the company has tapped the power of scientific discovery and innovation to advance the practice of medicine.
Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbuster medicines. Today, as a world leader in biotechnology serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness.